These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29547432)

  • 21. The American Opioid Epidemic: Population Health Implications and Potential Solutions. Report from the National Stakeholder Panel.
    Clarke JL; Skoufalos A; Scranton R
    Popul Health Manag; 2016 Mar; 19 Suppl 1():S1-10. PubMed ID: 26908092
    [No Abstract]   [Full Text] [Related]  

  • 22. Insights and issues from FDA Advisory Committee meetings on abuse-deterrent opioids.
    Miller CJ; Dart RC; Katz NP; Webster LR
    J Opioid Manag; 2017; 13(6):379-389. PubMed ID: 29308585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coupling Policymaking with Evaluation - The Case of the Opioid Crisis.
    Barnett ML; Gray J; Zink A; Jena AB
    N Engl J Med; 2017 Dec; 377(24):2306-2309. PubMed ID: 29236636
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA remodels REMS for opioid medications.
    Stone A
    ONS Connect; 2012 Sep; 27(9):18. PubMed ID: 23008909
    [No Abstract]   [Full Text] [Related]  

  • 25. The National Opioid Epidemic and the Risk of Outpatient Opioids in Children.
    Krane EJ; Weisman SJ; Walco GA
    Pediatrics; 2018 Aug; 142(2):. PubMed ID: 30012558
    [No Abstract]   [Full Text] [Related]  

  • 26. Reducing the Community-Prescribed Opioid Load: A Public Health Approach to the Opioid Epidemic.
    Lew J; Moore K
    J Opioid Manag; 2016; 12(4):235-7. PubMed ID: 27575823
    [No Abstract]   [Full Text] [Related]  

  • 27. Reframing the Prevention Strategies of the Opioid Crisis: Focusing on Prescription Opioids, Fentanyl, and Heroin Epidemic.
    Manchikanti L; Sanapati J; Benyamin RM; Atluri S; Kaye AD; Hirsch JA
    Pain Physician; 2018 Jul; 21(4):309-326. PubMed ID: 30045589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in misuse and abuse of prescription opioids following implementation of Extended-Release and Long-Acting Opioid Analgesic Risk Evaluation and Mitigation Strategy.
    Bucher Bartelson B; Le Lait MC; Green JL; Cepeda MS; Coplan PM; Maziere JY; Wedin GP; Dart RC
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1061-1070. PubMed ID: 28758289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the impact of the extended-release/long-acting opioid an-algesics risk evaluation and mitigation strategies on opioid prescrip-tion volume.
    Divino V; Cepeda MS; Coplan P; Maziere JY; Yuan Y; Wade RL
    J Opioid Manag; 2017; 13(3):157-168. PubMed ID: 28829517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abuse-deterrent formulations of opioids: Many questions still to answer.
    Brown RE
    J Opioid Manag; 2017; 13(6):353-356. PubMed ID: 29308581
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of Risk Evaluation and Mitigation Strategies by the US Food and Drug Administration, 2008-2019.
    Guadamuz JS; Qato DM; Alexander GC
    JAMA; 2020 Jul; 324(3):299-301. PubMed ID: 32692379
    [No Abstract]   [Full Text] [Related]  

  • 32. Evolution of the national opioid crisis.
    Morland R
    Nursing; 2019 May; 49(5):51-56. PubMed ID: 31022031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes.
    Cepeda MS; Coplan PM; Kopper NW; Maziere JY; Wedin GP; Wallace LE
    Pain Med; 2017 Jan; 18(1):78-85. PubMed ID: 27373304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid use disorder: A public health emergency.
    Alexander LM; Keahey D; Dixon K
    JAAPA; 2018 Oct; 31(10):47-52. PubMed ID: 30252764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A public health outbreak management framework applied to surges in opioid overdoses.
    Moore K; Boulet M; Lew J; Papadomanolakis-Pakis N
    J Opioid Manag; 2017; 13(5):273-281. PubMed ID: 29199393
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interpreting labels of abuse-deterrent opioid analgesics.
    Webster LR
    J Opioid Manag; 2017; 13(6):415-423. PubMed ID: 29308588
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Opioid Epidemic: Moving Toward an Integrated, Holistic Analytical Response.
    Morrow JB; Ropero-Miller JD; Catlin ML; Winokur AD; Cadwallader AB; Staymates JL; Williams SR; McGrath JG; Logan BK; McCormick MM; Nolte KB; Gilson TP; Menendez MJ; Goldberger BA
    J Anal Toxicol; 2019 Jan; 43(1):1-9. PubMed ID: 30165647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The opioid crisis in the USA: a public health emergency.
    The Lancet
    Lancet; 2017 Nov; 390(10107):2016. PubMed ID: 29115231
    [No Abstract]   [Full Text] [Related]  

  • 39. Addressing the Opioid Epidemic - Opportunities in the Postmarketing Setting.
    Psaty BM; Merrill JO
    N Engl J Med; 2017 Apr; 376(16):1502-1504. PubMed ID: 28423291
    [No Abstract]   [Full Text] [Related]  

  • 40. Pain treatment agreements.
    Rowe W
    Am J Bioeth; 2010 Nov; 10(11):3-4. PubMed ID: 21104544
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.